Ocular Therapeutix (NASDAQ: OCUL) reported Q1 EPS of ($0.39), $0.13 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $13.37 million versus the consensus estimate of $14.07 million.

For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.